Publish Date: 
Fri, 07/08/2016 - 19:08

Professor Martin Dreyling together with Associate Professor Judith Trotman will discuss RIBOMUSTIN’s (bendamustine hydrochloride) role in the treatment of indolent non-Hodgkin’s lymphoma (iNHL) and mantle cell lymphoma (MCL). Professor Martin Dreyling together with Associate Professor Judith Trotman will discuss RIBOMUSTIN’s (bendamustine hydrochloride) role in the treatment of indolent non-Hodgkin’s lymphoma (iNHL) and mantle cell lymphoma (MCL). Professor Martin Dreyling together with Associate Professor Judith Trotman will discuss RIBOMUSTIN’s (bendamustine hydrochloride) role in the treatment of indolent non-Hodgkin’s lymphoma (iNHL) and mantle cell lymphoma (MCL).